Modified Microneedle for Suprachoroidal Injection of Triamcinolone Acetonide Combined with Intravitreal Injection of Ranibizumab in Branch Retinal Vein Occlusion Patients

References

• Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–319. doi:10.1016/j.ophtha.2009.07.017
   PubMed Web of Science ®Google Scholar
• Noma H, Yasuda K, Shimura M. Cytokines and the pathogenesis of macular edema in branch retinal vein occlusion. J Ophthalmol. 2019;2019:1–9. doi:10.1155/2019/5185128
   Web of Science ®Google Scholar
• Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol. 1990;109(3):298–302. doi:10.1016/s0002-9394(14)74554-4
   PubMed Web of Science ®Google Scholar
• Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol. 1992;113(6):664–668. doi:10.1016/s0002-9394(14)74791-9
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Branch retinal vein occlusion: natural history of visual outcome. JAMA Ophthalmol. 2014;132(1):13–22. doi:10.1001/jamaophthalmol.2013.5515
   PubMed Web of Science ®Google Scholar
• Jonas J, Paques M, Mones J, Glacet-Bernard A. Retinal vein occlusions. Dev Ophthalmol. 2010;47:111–135. doi:10.1159/000320076
   PubMedGoogle Scholar
• Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res. 2014;41:1–25. doi:10.1016/j.preteyeres.2014.04.001
   PubMed Web of Science ®Google Scholar
• Kadomoto S, Muraoka Y, Uji A, Tamiya R, Oritani Y, Kawai K. Nonperfusion area quantification in branch retinal vein occlusion: a Widefield optical coherence tomography angiography study. Retina. 2021;41(6):1210–1218‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬. doi:10.1097/IAE.0000000000002999
   Web of Science ®Google Scholar
• Gawęcki M. Subthreshold diode micropulse laser combined with intravitreal therapy for macular edema—A systematized review and critical approach. J Clin Med. 2021;10(7):1394. doi:10.3390/jcm10071394
   PubMed Web of Science ®Google Scholar
• Barquet LA. Papel del factor de crecimiento del endotelio vascular en las enfermedades de la retina [Role of VEGF in diseases of the retina]. Arch Soc Esp Oftalmol. 2015;90:3–5. doi:10.1016/S0365-6691(15)30002-2
   PubMedGoogle Scholar
• Nozik RA. Periocular injection of steroids. Transactions-American Academy of Ophthalmology and Otolaryngology. Am Acad Ophthalmol Otolaryngol. 1972;76(3):695–705. PMID: 4677452.
   PubMedGoogle Scholar
• Munk MR, Bolz M, Huf W, et al. Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema. Retina. 2013;33(8):1673–1683. doi:10.1097/IAE.0b013e318285cc52
   PubMed Web of Science ®Google Scholar
• Urbancic M, Gardasevic Topcic I. Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective. Clin Ophthalmol. 2019;13:829–840. doi:10.2147/OPTH.S206769
   PubMed Web of Science ®Google Scholar
• Edelhauser HF, Verhoeven RS, Burke B, Struble CB, Patel SR. Intraocular distribution and targeting of triamcinolone acetonide suspension administered into the suprachoroidal space. Invest Ophthalmol Vis Sci. 2014;55(13):5259.
   Web of Science ®Google Scholar
• Campochiaro PA, Wykoff CC, Brown DM, et al. Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the tanzanite study. Ophthalmol Retina. 2018;2(4):320–328. doi:10.1016/j.oret.2017.07.013
   PubMedGoogle Scholar
• Gilger BC, Abarca EM, Salmon JH, Patel S. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Invest Ophthalmol Vis Sci. 2013;54(4):2483–2492. doi:10.1167/iovs.13-11747
   PubMed Web of Science ®Google Scholar
• Yeh S, Kurup SK, Wang RC, et al. Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, Phase 2 study (DOGWOOD). Retina. 2019;39(10):1880–1888. doi:10.1097/IAE.0000000000002279
   PubMed Web of Science ®Google Scholar
• Coscas G, Cunha-Vaz J, Soubrane G. Macular edema: definition and basic concepts. Dev Ophthalmol. 2010;47:1–9. doi:10.1159/000320070
   PubMedGoogle Scholar
• Augustin A, Loewenstein A, Kuppermann BD. General pathophysiology. Dev Ophthalmol. 2010;47:10–26. doi:10.1159/000320071
   PubMedGoogle Scholar
• Cimolai N. Comment on “Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines”. Int J Ophthalmol. 2020;13(8):1343–1344. doi:10.18240/ijo.2020.08.25
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Hafiz G, Mir TA, et al. Pro-permeability factors after dexamethasone implant in retinal vein occlusion; the Ozurdex for retinal vein occlusion (ORVO) study. Am J Ophthalmol. 2015;160(2):313–321. doi:10.1016/j.ajo.2015.04.025
   PubMed Web of Science ®Google Scholar
• Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci. 2012;53(8):4433–4441. doi:10.1167/iovs.12-9872
   PubMed Web of Science ®Google Scholar
• Park SH, Lee KJ, Lee J, et al. Microneedle-based minimally- invasive measurement of puncture resistance and fracture toughness of sclera. Acta Biomater. 2016;44:286–294. doi:10.1016/j.actbio.2016.08.011
   PubMed Web of Science ®Google Scholar
• Marashi A, Zazo A. A manually made needle for treating Pseudophakic cystoid macular edema by injecting triamcinolone acetonide in the suprachoroidal space: a case report. Am J Ophthalmol Case Rep. 2022;25:101254. doi:10.1016/j.ajoc.2021.101254
   PubMedGoogle Scholar
• Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology. 2014;121(1):209–219. doi:10.1016/j.ophtha.2013.08.038
   PubMed Web of Science ®Google Scholar
• Ali RI, Kapoor KG, Khan AN, Gibran SK. Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion. Indian J Ophthalmol. 2014;62(4):396. doi:10.4103/0301-4738.120227
   PubMedGoogle Scholar
• Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S. Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER. Ophthalmology. 2016;123(6):1332–1344. doi:10.1016/j.ophtha.2016.02.030
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a Phase III study. Ophthalmology. 2010;117(6):1102–1112. doi:10.1016/j.ophtha.2010.02.021
   PubMed Web of Science ®Google Scholar
• Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011;118(8):1594–1602. doi:10.1016/j.ophtha.2011.02.022
   PubMed Web of Science ®Google Scholar
• Battaglia Parodi M, Romano F, Arrigo A, Mercuri S, Franceschi A, Bandello F. Ranibizumab for macular edema secondary to central and branch retinal vein occlusion in patients younger than 50 years of age. Biomed Res Int. 2020;2020:1–7.
   Web of Science ®Google Scholar
• Zhang S, An N, Ha W, et al. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion. J Int Med Res. 2016;44(3):685–697. doi:10.1177/0300060515617386
   PubMed Web of Science ®Google Scholar